TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.

Hanmei Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.